Among them, high MKLN1-AS expression was previously reported to aggravate hepatocellular carcinoma progression and was associated with shorter overall survival and disease-free survival in patients with HCC (Gao et al., 2020). The gene discussed is MKLN1; the disease is hepatocellular carcinoma.